» Articles » PMID: 32013893

Dysregulation of TNF-α and IFN-γ Expression is a Common Host Immune Response in a Chronically Infected Mouse Model of Melioidosis when Comparing Multiple Human Strains of Burkholderia Pseudomallei

Abstract

Background: Melioidosis is endemic in Southeast Asia and Northern Australia and is caused by the Gram-negative, facultative intracellular pathogen Burkholderia pseudomallei. Diagnosis of melioidosis is often difficult because of the protean clinical presentation of the disease, and it may mimic other diseases, such as tuberculosis. There are many different strains of B. pseudomallei that have been isolated from patients with melioidosis, but it was not clear if they could cause a similar disease in a chronic BALB/c murine model of melioidosis. Hence, we wanted to examine chronically infected mice exposed to different strains of B. pseudomallei to determine if there were differences in the host immune response to the pathogen.

Results: We identified common host immune responses exhibited in chronically infected BALB/c mice, although there was some heterogeneity in the host response in chronically infected mice after exposure to different strains of B. pseudomallei. They all displayed pyogranulomatous lesions in their spleens with a large influx of monocytes/macrophages, NK cells, and neutrophils identified by flow cytometry. Sera from chronically infected mice by ELISA exhibited elevated IgG titers to the pathogen, and we detected by Luminex micro-bead array technology a significant increase in the expression of inflammatory cytokines/chemokines, such as IFN-γ, IL-1α, IL-1β, KC, and MIG. By immunohistochemical and in situ RNA hybridization analysis we found that the increased expression of proinflammatory cytokines (IL-1α, IL-1β, TNF-α, IFN-γ) was confined primarily to the area with the pathogen within pyogranulomatous lesions. We also found that cultured splenocytes from chronically infected mice could express IFN-γ, TNF-α, and MIP-1α ex vivo without the need for additional exogenous stimulation. In addition by flow cytometry, we detected significant amounts of intracellular expression of TNF-α and IFN-γ without a protein transport blocker in monocytes/macrophages, NK cells, and neutrophils but not in CD4 or CD8 T cells in splenocytes from chronically infected mice.

Conclusion: Taken together the common features we have identified in chronically infected mice when 10 different human clinical strains of B. pseudomallei were examined could serve as biomarkers when evaluating potential therapeutic agents in mice for the treatment of chronic melioidosis in humans.

Citing Articles

Role of the type 6 secretion system on apoptosis and macrophage polarization during Burkholderia pseudomallei infection.

Stockton J, Khakhum N, Torres A PLoS Negl Trop Dis. 2024; 18(10):e0012585.

PMID: 39405316 PMC: 11508161. DOI: 10.1371/journal.pntd.0012585.


BicA protein promotes pathogenicity in macrophages by regulating invasion, intracellular survival, and virulence.

Stockton J, Khakhum N, Stevenson H, Torres A mSphere. 2023; 8(5):e0037823.

PMID: 37768049 PMC: 10597401. DOI: 10.1128/msphere.00378-23.


Intranasal immunization with a Bucl8-based vaccine ameliorates bacterial burden and pathological inflammation, and promotes an IgG2a/b dominant response in an outbred mouse model of infection.

Grund M, Choi S, Powell L, Lukomski S Front Immunol. 2023; 14:1177650.

PMID: 37545515 PMC: 10399622. DOI: 10.3389/fimmu.2023.1177650.


Methodological tools to study species of the genus Burkholderia.

Scoffone V, Trespidi G, Barbieri G, Irudal S, Israyilova A, Buroni S Appl Microbiol Biotechnol. 2021; 105(24):9019-9034.

PMID: 34755214 PMC: 8578011. DOI: 10.1007/s00253-021-11667-3.


Immunity in Atherosclerosis: Focusing on T and B Cells.

Poznyak A, Bezsonov E, Popkova T, Starodubova A, Orekhov A Int J Mol Sci. 2021; 22(16).

PMID: 34445084 PMC: 8395064. DOI: 10.3390/ijms22168379.


References
1.
Bold T, Ernst J . CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection. J Immunol. 2012; 189(5):2530-6. PMC: 3424308. DOI: 10.4049/jimmunol.1200994. View

2.
Trevino S, Klimko C, Reed M, Aponte-Cuadrado M, Hunter M, Shoe J . Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei. PLoS One. 2018; 13(11):e0208277. PMC: 6267979. DOI: 10.1371/journal.pone.0208277. View

3.
Jiang Y, Li Y, Zhu B . T-cell exhaustion in the tumor microenvironment. Cell Death Dis. 2015; 6:e1792. PMC: 4669840. DOI: 10.1038/cddis.2015.162. View

4.
Buddhisa S, Rinchai D, Ato M, Bancroft G, Lertmemongkolchai G . Programmed death ligand 1 on Burkholderia pseudomallei-infected human polymorphonuclear neutrophils impairs T cell functions. J Immunol. 2015; 194(9):4413-21. DOI: 10.4049/jimmunol.1402417. View

5.
Sarovich D, Price E, Von Schulze A, Cook J, Mayo M, Watson L . Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia. PLoS One. 2012; 7(2):e30789. PMC: 3283585. DOI: 10.1371/journal.pone.0030789. View